NCT03472313View on ClinicalTrials.gov

Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

April 20, 2018

Study Completion Date

April 20, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

[18F]MNI-958

Healthy Volunteers recruited for the study will undergo a single \[18F\]MNI-958 injection and PET scan.

Trial Locations (1)

06510

Invicro, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Invicro

OTHER